ARISTOTLE: Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction
Sponsor
Sun Yat-sen University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06069232
Collaborator
First Affiliated Hospital, Sun Yat-Sen University (Other), Third Affiliated Hospital, Sun Yat-Sen University (Other), Affiliated Hospital of Guangdong Medical University (Other), Second Affiliated Hospital of Medical College Shandong University (Other), Eighth Affiliated Hospital, Sun Yat-sen University (Other), Zhongshan People's Hospital, Guangdong, China (Other), Jieyang People's Hospital (Other)
2,000
7
84
285.7
3.4
Study Details
Study Description
Brief Summary
This study is a multicenter cohort study including patients diagnosed with aortic valve disease during hospitalization, including aortic insufficiency and aortic valve stenosis. The primary outcome of the study was all-cause death, and the secondary outcome was cardiovascular events. Through follow-up observation, the prognostic risk factors of patients with aortic disease were evaluated, and a prognostic model was constructed to guide clinical decision-making.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
2000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction (ARISTOTLE)
Actual Study Start Date
:
Mar 1, 2021
Anticipated Primary Completion Date
:
Mar 1, 2028
Anticipated Study Completion Date
:
Mar 1, 2028
Outcome Measures
Primary Outcome Measures
- all-cause mortality [from baseline to death or end of follow-up]
death caused by any cause
Secondary Outcome Measures
- Cardiovascular death [from baseline to death or end of follow-up]
Death caused by cardiac causes
- Aortic valve replacement [from baseline to aortic valve replacement]
Transcatheter aortic valve replacement or surgical aortic valve replacement
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 100 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
-
age ≥ 18
-
diagnosed as aortic valve disease
Exclusion Criteria:
- aortic valve replacement at baseline
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | First Affiliated Hospital, Sun Yat-Sen University | Guangzhou | Guangdong | China | 510000 |
2 | Third Affiliated Hospital, Sun Yat-Sun University | Guangzhou | Guangdong | China | 510000 |
3 | Jieyang People's Hospital | Jieyang | Guangdong | China | 522000 |
4 | Second Affiliated Hospital of Shantou University Medical College | Shantou | Guangdong | China | 515041 |
5 | Eighth Affiliated Hospital, Sun Yat-Sen University | Shenzhen | Guangdong | China | 518000 |
6 | Affiliated Hospital of Guangdong Medical University | Zhanjiang | Guangdong | China | 524001 |
7 | Zhongshan People's Hospital | Zhongshan | Guangdong | China | 528400 |
Sponsors and Collaborators
- Sun Yat-sen University
- First Affiliated Hospital, Sun Yat-Sen University
- Third Affiliated Hospital, Sun Yat-Sen University
- Affiliated Hospital of Guangdong Medical University
- Second Affiliated Hospital of Medical College Shandong University
- Eighth Affiliated Hospital, Sun Yat-sen University
- Zhongshan People's Hospital, Guangdong, China
- Jieyang People's Hospital
Investigators
- Principal Investigator: xiaodong zhuang, PhD, First Affiliated Hospital, Sun Yat-Sen University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Xiao-dong Zhuang,
Professor,
Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT06069232
Other Study ID Numbers:
- ARISTOTLE Study
First Posted:
Oct 5, 2023
Last Update Posted:
Oct 5, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Xiao-dong Zhuang,
Professor,
Sun Yat-sen University
Additional relevant MeSH terms: